Section I
2181 – 2190 of 4733
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma - a Nordic Lymphoma Group study.
(
- Contribution to journal › Article
-
Mark
Genome-wide DNA methylation analysis of lung carcinoma reveals one neuroendocrine and four adenocarcinoma epitypes associated with patient outcome.
(
- Contribution to journal › Article
-
Mark
Somatic BRAF and NRAS Mutations in Familial Melanomas with Known Germline CDKN2A Status: A GenoMEL Study
(
- Contribution to journal › Letter
-
Mark
Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer
(
- Contribution to journal › Article
-
Mark
Key Roles for MYC, KIT and RET signaling in secondary angiosarcomas.
(
- Contribution to journal › Article
-
Mark
Glycaemic control in end-of-life care: fundamental or futile?
(
- Contribution to journal › Scientific review
-
Mark
Prediagnostic immunoglobulin E levels and risk of chronic lymphocytic leukemia, other lymphomas and multiple myeloma-results of the European Prospective Investigation into Cancer and Nutrition.
(
- Contribution to journal › Article
-
Mark
Anal carcinoma - Survival and recurrence in a large cohort of patients treated according to Nordic guidelines.
(
- Contribution to journal › Article
-
Mark
Prediagnostic intake of dairy products and dietary calcium and colorectal cancer survival - results from the EPIC cohort study.
(
- Contribution to journal › Article
-
Mark
The Target for Statins, HMG-CoA Reductase, Is Expressed in Ductal Carcinoma-In Situ and May Predict Patient Response to Radiotherapy.
(
- Contribution to journal › Article